These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 23676497)

  • 1. Endocytosis of synaptic ADAM10 in neuronal plasticity and Alzheimer's disease.
    Marcello E; Saraceno C; Musardo S; Vara H; de la Fuente AG; Pelucchi S; Di Marino D; Borroni B; Tramontano A; Pérez-Otaño I; Padovani A; Giustetto M; Gardoni F; Di Luca M
    J Clin Invest; 2013 Jun; 123(6):2523-38. PubMed ID: 23676497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ADAM10 in synaptic physiology and pathology.
    Musardo S; Marcello E; Gardoni F; Di Luca M
    Neurodegener Dis; 2014; 13(2-3):72-4. PubMed ID: 24008925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SAP97-mediated ADAM10 trafficking from Golgi outposts depends on PKC phosphorylation.
    Saraceno C; Marcello E; Di Marino D; Borroni B; Claeysen S; Perroy J; Padovani A; Tramontano A; Gardoni F; Di Luca M
    Cell Death Dis; 2014 Nov; 5(11):e1547. PubMed ID: 25429624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An arginine stretch limits ADAM10 exit from the endoplasmic reticulum.
    Marcello E; Gardoni F; Di Luca M; Pérez-Otaño I
    J Biol Chem; 2010 Apr; 285(14):10376-84. PubMed ID: 20100836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blocking ADAM10 synaptic trafficking generates a model of sporadic Alzheimer's disease.
    Epis R; Marcello E; Gardoni F; Vastagh C; Malinverno M; Balducci C; Colombo A; Borroni B; Vara H; Dell'Agli M; Cattabeni F; Giustetto M; Borsello T; Forloni G; Padovani A; Di Luca M
    Brain; 2010 Nov; 133(11):3323-35. PubMed ID: 20805102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The development of ADAM10 endocytosis inhibitors for the treatment of Alzheimer's disease.
    Musardo S; Therin S; Pelucchi S; D'Andrea L; Stringhi R; Ribeiro A; Manca A; Balducci C; Pagano J; Sala C; Verpelli C; Grieco V; Edefonti V; Forloni G; Gardoni F; Meli G; Di Marino D; Di Luca M; Marcello E
    Mol Ther; 2022 Jul; 30(7):2474-2490. PubMed ID: 35390543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of peroxisome proliferator-activated receptor α stimulates ADAM10-mediated proteolysis of APP.
    Corbett GT; Gonzalez FJ; Pahan K
    Proc Natl Acad Sci U S A; 2015 Jul; 112(27):8445-50. PubMed ID: 26080426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TspanC8 Tetraspanins and A Disintegrin and Metalloprotease 10 (ADAM10) Interact via Their Extracellular Regions: EVIDENCE FOR DISTINCT BINDING MECHANISMS FOR DIFFERENT TspanC8 PROTEINS.
    Noy PJ; Yang J; Reyat JS; Matthews AL; Charlton AE; Furmston J; Rogers DA; Rainger GE; Tomlinson MG
    J Biol Chem; 2016 Feb; 291(7):3145-57. PubMed ID: 26668317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synapse-associated protein-97 mediates alpha-secretase ADAM10 trafficking and promotes its activity.
    Marcello E; Gardoni F; Mauceri D; Romorini S; Jeromin A; Epis R; Borroni B; Cattabeni F; Sala C; Padovani A; Di Luca M
    J Neurosci; 2007 Feb; 27(7):1682-91. PubMed ID: 17301176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amyloid-β Oligomers Regulate ADAM10 Synaptic Localization Through Aberrant Plasticity Phenomena.
    Marcello E; Musardo S; Vandermeulen L; Pelucchi S; Gardoni F; Santo N; Antonucci F; Di Luca M
    Mol Neurobiol; 2019 Oct; 56(10):7136-7143. PubMed ID: 30989630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of mRNA and Protein Levels of
    Di Maio A; De Rosa A; Pelucchi S; Garofalo M; Marciano B; Nuzzo T; Gardoni F; Isidori AM; Di Luca M; Errico F; De Bartolomeis A; Marcello E; Usiello A
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-144 is regulated by activator protein-1 (AP-1) and decreases expression of Alzheimer disease-related a disintegrin and metalloprotease 10 (ADAM10).
    Cheng C; Li W; Zhang Z; Yoshimura S; Hao Q; Zhang C; Wang Z
    J Biol Chem; 2013 May; 288(19):13748-61. PubMed ID: 23546882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surface expression and limited proteolysis of ADAM10 are increased by a dominant negative inhibitor of dynamin.
    Carey RM; Blusztajn JK; Slack BE
    BMC Cell Biol; 2011 May; 12():20. PubMed ID: 21586144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tetraspanin 3: A central endocytic membrane component regulating the expression of ADAM10, presenilin and the amyloid precursor protein.
    Seipold L; Damme M; Prox J; Rabe B; Kasparek P; Sedlacek R; Altmeppen H; Willem M; Boland B; Glatzel M; Saftig P
    Biochim Biophys Acta Mol Cell Res; 2017 Jan; 1864(1):217-230. PubMed ID: 27818272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dysregulated ADAM10-Mediated Processing of APP during a Critical Time Window Leads to Synaptic Deficits in Fragile X Syndrome.
    Pasciuto E; Ahmed T; Wahle T; Gardoni F; D'Andrea L; Pacini L; Jacquemont S; Tassone F; Balschun D; Dotti CG; Callaerts-Vegh Z; D'Hooge R; Müller UC; Di Luca M; De Strooper B; Bagni C
    Neuron; 2015 Jul; 87(2):382-98. PubMed ID: 26182420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ADAM9 inhibition increases membrane activity of ADAM10 and controls α-secretase processing of amyloid precursor protein.
    Moss ML; Powell G; Miller MA; Edwards L; Qi B; Sang QX; De Strooper B; Tesseur I; Lichtenthaler SF; Taverna M; Zhong JL; Dingwall C; Ferdous T; Schlomann U; Zhou P; Griffith LG; Lauffenburger DA; Petrovich R; Bartsch JW
    J Biol Chem; 2011 Nov; 286(47):40443-51. PubMed ID: 21956108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of neuron-specific ADAM10 modulation in an in vivo model of acute excitotoxic stress.
    Clement AB; Hanstein R; Schröder A; Nagel H; Endres K; Fahrenholz F; Behl C
    Neuroscience; 2008 Mar; 152(2):459-68. PubMed ID: 18276079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. nELAV proteins alteration in Alzheimer's disease brain: a novel putative target for amyloid-beta reverberating on AbetaPP processing.
    Amadio M; Pascale A; Wang J; Ho L; Quattrone A; Gandy S; Haroutunian V; Racchi M; Pasinetti GM
    J Alzheimers Dis; 2009; 16(2):409-19. PubMed ID: 19221430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ADAM10 missense mutations potentiate β-amyloid accumulation by impairing prodomain chaperone function.
    Suh J; Choi SH; Romano DM; Gannon MA; Lesinski AN; Kim DY; Tanzi RE
    Neuron; 2013 Oct; 80(2):385-401. PubMed ID: 24055016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel blood-brain barrier co-culture system for drug targeting of Alzheimer's disease: establishment by using acitretin as a model drug.
    Freese C; Reinhardt S; Hefner G; Unger RE; Kirkpatrick CJ; Endres K
    PLoS One; 2014; 9(3):e91003. PubMed ID: 24608847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.